Genetic Determinants of Myocarditis Induced by Immune-checkpoint Inhibitors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genetic Determinants of Myocarditis Induced by Immune-checkpoint Inhibitors — Stella

Home/ICI-myocarditis/

View on ClinicalTrials.gov

Recruiting

Back to ICI-myocarditis trials

Trial locations(1 site)

France

Hôpital Pitié Salpêtrière, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~500 participants

Started

September 2025

Primary completion

January 2028

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.